Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$4 Mln
P/E Ratio
--
P/B Ratio
0.15
Industry P/E
--
Debt to Equity
0.42
ROE
-0.31 %
ROCE
-38.78 %
Div. Yield
0 %
Book Value
--
EPS
--
CFO
$-58.24 Mln
EBITDA
$-109.32 Mln
Net Profit
$-76.66 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Medigus - ADR (MDGS)
| -46.93 | -9.42 | -35.93 | -64.40 | -58.02 | -44.03 | -- |
|
BSE Sensex*
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Medigus - ADR (MDGS)
| -30.19 | -68.87 | -47.64 | 9.77 | -33.08 | -50.57 | -76.64 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 15.10 | 10,493.89 | 14.66 | 12.69 | |
| 71.01 | 9,784.74 | 94.85 | 2.52 | |
| 152.15 | 8,196.06 | -- | -25.23 | |
| 277.35 | 10,699.33 | 771.64 | 1.2 |
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic... Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel. Read more
Chief Executive Officer
Mr. Liron Carmel
Chief Executive Officer
Mr. Liron Carmel
Headquarters
Tel Aviv
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Medigus Ltd - ADR (MDGS) stood at $ 64 Mln as on 31-Dec-23
The share price of Medigus Ltd - ADR (MDGS) is $1.73 (NASDAQ) as of 18-Jun-2024 09:30 EDT. Medigus Ltd - ADR (MDGS) has given a return of -58.02% in the last 3 years.
Medigus Ltd - ADR (MDGS) has a market capitalisation of $ 4 Mln as on 18-Jun-2024. As per Value Research classification, it is a company.
Since, TTM earnings of Medigus Ltd - ADR (MDGS) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Medigus Ltd - ADR (MDGS) and enter the required number of quantities and click on buy to purchase the shares of Medigus Ltd - ADR (MDGS).
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.
The CEO & director of Mr. Liron Carmel. is Medigus Ltd - ADR (MDGS), and CFO & Sr. VP is Mr. Liron Carmel.
There is no promoter pledging in Medigus Ltd - ADR (MDGS).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,083
|
|
|
1,061
|
|
|
1,022
|
|
|
889
|
| Medigus Ltd. - ADR (MDGS) | Ratios |
|---|---|
|
Return on equity(%)
|
-51.1
|
|
Operating margin(%)
|
-18.34
|
|
Net Margin(%)
|
-17.47
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Medigus Ltd - ADR (MDGS) was $-16 Mln.
$-3.14
(
